Evidence map›Paper›PMID 35075606›Full record

Observational studyJournal of cardiovascular translational research2022

Could Selective Re-look Angiography Improve the Outcome of Cardiogenic Shock in Patients Under Veno-arterial Extracorporeal Membrane Oxygenator?

Maurice Maksoud, Amr S Omar, Praveen Sivadasan, Tamer Abdalghafoor, Alaa Rahhal, Tasnim Abdalla, Bassam Shoman, Rula Taha, Abdulaziz AlKhulaifi

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of cardiovascular translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Maurice MaksoudDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar.
Amr S OmarDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar. a_s_omar@yahoo.com.ORCID 0000-0001-8560-2745
Praveen SivadasanDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar.ORCID 0000-0001-5811-122X
Tamer AbdalghafoorDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar.ORCID 0000-0002-1254-6487
Alaa RahhalDepartment of Clinical Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-2631-0184
Tasnim AbdallaFaculty of Medicine, Qatar University, Doha, Qatar.ORCID 0000-0002-2511-4886
Bassam ShomanDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar.
Rula TahaDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar.
Abdulaziz AlKhulaifiDepartment of Cardiothoracic Surgery/Cardiac Anaesthesia & ICU Section, Heart Hospital, Hamad Medical Corporation, Doha, PO: 3050, Qatar.ORCID 0000-0002-3521-1364
Hamad Medical Corporation · QABeni-Suef University · EGQatar University · QA

Funding

hamad medical corporation MRC-01-20-096
6 · The paper itself

Abstract

It is not well studied whether a secondary look by angiography (Re-Ang) after fixing the culprit lesion would be beneficial or not in cardiogenic shock (CS) supported by veno-arterial extracorporeal membrane oxygenator (VA-ECMO). This study was a retrospective observational one that looked at 5-year data from a single tertiary center. Patients were grouped according to the need of Re-Ang during the VA-ECMO course into 2 groups. The indications to perform Re-Ang were loss of pulse pressure, drop in ejection fraction or velocity time integral, resistant arrhythmia, or new electrocardiographic changes suggestive of ischemia. Out of 150 patients with cardiogenic shock screened, 30 patients were enrolled in our study. Re-Ang was done in 10 patients only. In 80% of them, positive findings were found in terms of new significant stenosis (3 patients), stent restenosis (1 patient), stent thrombosis (3 patients), and patent stent(s) with intervention to the remaining lesions in other vessels (1 patient). Neither successful weaning from VA-ECMO nor mortality was statistically different between both groups. Our set indications for Re-Ang were effective in finding a possible new culprit for a conceivable coronary intervention.

Indexed as

Extracorporeal Membrane OxygenationShock, CardiogenicAngiographyHumansOxygenators, MembraneRetrospective StudiesAngiographyCardiogenic shockECMO

Identifiers

PMID35075606
OpenAlexW4206901971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.